<p>To develop consensus recommendations for the selection and management of vascular access devices (VADs) in oncology patients in India by addressing unique challenges in the Indian healthcare ecosystem. An expert panel of 11 specialists in oncology and interventional radiology convened to review literature and develop consensus statements on 10 key questions related to the selection of VAD in cancer patients. The panel used a nominal group technique during a face-to-face meeting, achieving 100% consensus on all statements through structured discussions. The panel deliberated and agreed upon 10 consensus statements, addressing the indications for central venous access devices (CVADs), available CVAD options, clinical decision-making processes for identifying appropriate CVADs for different groups of patient, decision-makers for device selection and insertion, factors influencing port selection, the logistical requirements and CVAD maintenance protocols in cancer patients in India. Key recommendations emphasize the use of CVADs for administering vesicant drugs, considering both external catheters and implantable ports based on the duration and frequency of treatment. The recommendations also highlight the importance of involving multidisciplinary teams in device selection and implementing standardized training and protocols for insertion and maintenance. These consensus recommendations provide guidance on VAD selection and management tailored to the Indian oncology setting. The statements emphasize the importance of patient-centred decision-making, proper training for healthcare providers, and the need for increased awareness and education to enhance the appropriate adoption of implantable ports in India. Implementation of these recommendations may improve vascular access care and outcomes for cancer patients across diverse healthcare environments in India.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Indian Expert Consensus on the Selection of Vascular Access Devices in Oncology Patients

  • Somashekhar S. P.,
  • Bharat Gupta,
  • D. G. Vijay,
  • Geeta Kadayaprath,
  • Manjiri Somashekhar,
  • Manjula Rao,
  • Rahul Chowdhary,
  • Raghunandan Prasad,
  • Sanjeev Kumar Patni,
  • Shirish S. Alurkar,
  • Mohammad Jahanzeb

摘要

To develop consensus recommendations for the selection and management of vascular access devices (VADs) in oncology patients in India by addressing unique challenges in the Indian healthcare ecosystem. An expert panel of 11 specialists in oncology and interventional radiology convened to review literature and develop consensus statements on 10 key questions related to the selection of VAD in cancer patients. The panel used a nominal group technique during a face-to-face meeting, achieving 100% consensus on all statements through structured discussions. The panel deliberated and agreed upon 10 consensus statements, addressing the indications for central venous access devices (CVADs), available CVAD options, clinical decision-making processes for identifying appropriate CVADs for different groups of patient, decision-makers for device selection and insertion, factors influencing port selection, the logistical requirements and CVAD maintenance protocols in cancer patients in India. Key recommendations emphasize the use of CVADs for administering vesicant drugs, considering both external catheters and implantable ports based on the duration and frequency of treatment. The recommendations also highlight the importance of involving multidisciplinary teams in device selection and implementing standardized training and protocols for insertion and maintenance. These consensus recommendations provide guidance on VAD selection and management tailored to the Indian oncology setting. The statements emphasize the importance of patient-centred decision-making, proper training for healthcare providers, and the need for increased awareness and education to enhance the appropriate adoption of implantable ports in India. Implementation of these recommendations may improve vascular access care and outcomes for cancer patients across diverse healthcare environments in India.